Page last updated: 2024-11-05

thalidomide and Congenital Infection, Toxoplasma gondii

thalidomide has been researched along with Congenital Infection, Toxoplasma gondii in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morgon, A1
Charachon, D1
Bringuier, N1
Plum, P1

Other Studies

2 other studies available for thalidomide and Congenital Infection, Toxoplasma gondii

ArticleYear
Disorders of the auditory apparatus caused by embryopathy or foetopathy: prophylaxis and treatment (a) deafness as a result of congenital malformations occurring during the first three months (b) deafness resulting from diseases of the foetus occurring af
    Acta oto-laryngologica. Supplementum, 1971, Volume: 291

    Topics: Child, Preschool; Deafness; Ear; Ear, Inner; Female; Humans; Pregnancy; Pregnancy Complications; Rad

1971
[Human genetic perspectives. Antenatal and perinatal exogenous disease causes].
    Nordisk medicin, 1966, Jul-21, Volume: 76, Issue:29

    Topics: Abnormalities, Drug-Induced; Asphyxia Neonatorum; Brain Diseases; Genetics, Medical; Humans; Infant,

1966